https://www.aignostics.com https://www.aignostics.com/company/about https://www.aignostics.com/company/careers https://www.aignostics.com/publications https://www.aignostics.com/contact https://www.aignostics.com/news https://www.aignostics.com/blog https://www.aignostics.com/case-studies https://www.aignostics.com/events https://www.aignostics.com/products/foundation-models https://www.aignostics.com/services https://www.aignostics.com/privacy-policy https://www.aignostics.com/impressum https://www.aignostics.com/products/atlas-he-tme https://www.aignostics.com/products/atlas-he-tme/for-life-sciences https://www.aignostics.com/search https://www.aignostics.com/products/atlas-he-tme/for-academics https://www.aignostics.com/blog/aacr2025-from-bench-to-bedside-generalizable-ai-model-for-adc-biomarker-evaluation-in-nsclc https://www.aignostics.com/blog/asco2025-enhancing-prognostic-precision-in-bladder-cancer-ai-driven-tumor-microenvironment-analysis-from-h-e-images https://www.aignostics.com/blog/atlas-2-setting-a-new-standard-for-pathology-foundation-models https://www.aignostics.com/blog/atlas-h-e-tme-a-self-service-tool-for-comprehensive-analysis-of-the-tumor-microenvironment-tme https://www.aignostics.com/blog/ecdp2025-explainable-ai-for-weakly-supervised-membrane-expression-scoring https://www.aignostics.com/blog/iwd-2026-what-imposter-syndrome-looks-like-from-the-inside https://www.aignostics.com/blog/meet-jonathan-striebel-senior-machine-learning-software-engineer-on-our-ml-engineering-team https://www.aignostics.com/blog/meet-kwadjo-nyante-emba-msc2-cissp-chief-information-security-officer-at-aignostics https://www.aignostics.com/blog/meet-natalie-batty-senior-regulatory-affairs-specialist-on-our-regulatory-compliance-team https://www.aignostics.com/blog/meet-neelay-shah-machine-learning-engineer-on-our-data-processing-team https://www.aignostics.com/blog/meet-pd-dr-med-julika-ribbat-idel-ifcap-principal-pathologist-on-our-pathology-team https://www.aignostics.com/blog/meet-srishti-munjal-mehta-scientific-program-manager-on-our-translational-programs-team https://www.aignostics.com/blog/meet-the-pets-of-aignostics https://www.aignostics.com/blog/meetaignostics-timo-haschler-senior-scientific-project-manager-on-our-target-and-biomarker-discovery-team https://www.aignostics.com/blog/pathologys-evolution-how-aignostics-builds-on-charite-berlins-300-year-legacy https://www.aignostics.com/blog/towards-robust-foundation-models-for-digital-pathology https://www.aignostics.com/news/aignostics-achieves-iso-13485-certification-to-support-clinical-research-and-diagnostics-development https://www.aignostics.com/news/aignostics-and-bayer-to-present-on-joint-target-id-platform-at-esmo-ai https://www.aignostics.com/news/aignostics-and-virchow-laboratories-collaborate-to-offer-ai-powered-pathology-in-china https://www.aignostics.com/news/aignostics-announces-early-access-for-atlas-h-e-tme https://www.aignostics.com/news/aignostics-announces-new-state-of-the-art-pathology-foundation-model https://www.aignostics.com/news/aignostics-announces-results-for-pathology-foundation-model-developed-in-collaboration-with-mayo-clinic https://www.aignostics.com/news/aignostics-closes-e5m-seed-funding-round https://www.aignostics.com/news/aignostics-expands-atlas-h-e-tme-to-three-new-cancer-types https://www.aignostics.com/news/aignostics-foundation-model-for-histopathology-takes-the-lead-on-key-benchmarks https://www.aignostics.com/news/aignostics-launches-ai-powered-application-for-tumor-microenvironment-profiling https://www.aignostics.com/news/aignostics-launches-dedicated-initiative-for-the-academic-research-community https://www.aignostics.com/news/aignostics-obtains-iso-27001-recertification-underscoring-commitment-to-information-security https://www.aignostics.com/news/aignostics-presenting-new-research-and-collaborations-at-aacr-2023 https://www.aignostics.com/news/aignostics-raises-eu-14-million-series-a https://www.aignostics.com/news/aignostics-secures-34-million-series-b-to-enhance-precision-medicine-with-ai https://www.aignostics.com/news/aignostics-takes-home-prize-at-the-spark-german-digital-awards https://www.aignostics.com/news/aignostics-ultivue https://www.aignostics.com/news/aignostics-wins-eu-1-4-million-profit-funding https://www.aignostics.com/news/algorithms-will-not-replace-pathologists https://www.aignostics.com/news/bayer-and-aignostics-to-collaborate-on-next-generation-precision-oncology https://www.aignostics.com/news/iso-27001-certificate https://www.aignostics.com/news/machine-learning-improves-the-diagnosis-of-patients-with-head-and-neck-cancers https://www.aignostics.com/news/machine-learning-in-pathology-making-complex-data-visible-and-interpreting https://www.aignostics.com/news/precise-diagnostics-with-ai-bih-digital-health-accelerator-guides-aignostics-gmbh-through-its-spin-off https://www.aignostics.com/news/the-two-faces-of-intelligent-assistants https://www.aignostics.com/news/we-welcome-gerald-moeller-as-new-member-of-our-board-of-directors https://www.aignostics.com/news/welcome-emmanuel-blin-chairman-of-the-board https://www.aignostics.com/news/welcome-jessica-riley https://www.aignostics.com/news/when-a-computer-decides-on-therapy https://www.aignostics.com/case-studies/ai-based-anomaly-detection https://www.aignostics.com/case-studies/aignostics-foundation-model-enhance-generalizability-digital-pathology-ai https://www.aignostics.com/case-studies/atlas-h-e-tme-ai-powered-tumor-microenvironment-analysis-coverage-and-validation-benchmarks https://www.aignostics.com/case-studies/atlas-h-e-tme-ai-powered-tumor-microenvironment-analysis-product-overview https://www.aignostics.com/case-studies/improves-prediction-performance-drives-label-efficiency https://www.aignostics.com/case-studies/rediscovering-known-biology-validating-the-aignostics-bayer-target-id-platform